Switch View
© Globe Newswire
03.11.2025
ISIN: US74065P1012
Prelude Therapeutics Inc
PRLD
LISTED
NASDAQ
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting
News Preview
WILMINGTON, Del., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, today announced the publication of two abstracts with preclinical data on the Company’s JAK2V617F mutant selective inhibitors and CALR-targeted degrader antibody conjugates...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US9032141049
Cogent Biosciences, Inc.
COGT
LISTED
NASDAQ
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results
News Preview
Phase 3 PEAK results in 2nd-line GIST patients expected in November; pivotal APEX results in AdvSM patients expected in December...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter of Oklahoma Offers Health Insurance in Oklahoma in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable plans from Ambetter of Oklahoma in 43 counties.
OKLAHOMA CITY, Nov. 3, 2025 /PRNewswire/ -- Ambetter of Oklahoma, a product offered by a Centene Corporation (NYSE: CNC) company, a leading healthcare enter...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
03.11.2025
ISIN: US28036F1057
Edgewise Therapeutics Inc
EWTX
LISTED
NASDAQ
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
News Preview
BOULDER, Colo., Nov. 3, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions, today announced that on October 31, 2025, Edgewise grant...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter from Louisiana Healthcare Connections Offers Health Insurance in Louisiana in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable Ambetter from Louisiana Healthcare Connections plans in 22 parishes.
BATON ROUGE, La., Nov. 3, 2025 /PRNewswire/ -- Ambetter from Louisiana Healthcar...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US1011371077
Boston Scientific Corp
BSX
LISTED
NYSE
Boston Scientific announces upcoming investor conference schedule
News Preview
MARLBOROUGH, Mass., Nov. 3, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.
On November 18,...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: GB00BN4HT335
Indivior PLC
INDV
LISTED
NASDAQ
Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine
News Preview
Medicaid and commercially insured patients with high adherence to SUBLOCADE® experienced lower relapse rates and reduced healthcare resource utilization
Adherence to SUBLOCADE was associated with lower rates of infectious disease compl...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter of Tennessee Offers Health Insurance in Tennessee in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable
Ambetter of Tennessee plans statewide.
MEMPHIS, Tenn., Nov. 3, 2025 /PRNewswire/ -- Ambetter of Tennessee, a product offered by a Centene Corpor...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter from Home State Health Offers Health Insurance in Missouri in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable Ambetter from Home State Health plans in 109 counties.
ST. LOUIS, Nov. 3, 2025 /PRNewswire/ -- Ambetter from Home State Health, a product offered by a Centene Corporation (NYSE: CNC) company, a leading hea...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter from Superior HealthPlan and Ambetter Health Offer Health Insurance in Texas in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable plans from Ambetter from Superior HealthPlan in 150 counties.
AUSTIN, Texas, Nov. 3, 2025 /PRNewswire/ -- Ambetter from Superior HealthPlan and Ambetter Health, products offered by Centene Corporation (NYSE...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter of Alabama Offers Health Insurance in Alabama in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable Ambetter of Alabama plans in 40 counties.
HUNTSVILLE, Ala., Nov. 3, 2025 /PRNewswire/ -- Ambetter of Alabama, a product offered by a Centene Corporation (NYSE: CNC) company, a leading healthcare enterpris...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter from Sunflower Health Plan Offers Health Insurance in Kansas in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable Ambetter from Sunflower Health Plan plans in 91 counties.
LENEXA, Kan., Nov. 3, 2025 /PRNewswire/ -- For more than seven years, Ambetter from Sunflower Health Plan has helped Kansans access affordable,...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter Health Offers Health Insurance in Nebraska in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable Ambetter Health plans statewide.
OMAHA, Neb., Nov. 3, 2025 /PRNewswire/ -- Ambetter Health, a product offered by a Centene Corporation (NYSE: CNC) company, a leading healthcare enterprise that provides ins...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US67080M1036
Nurix Therapeutics Inc
NRIX
LISTED
NASDAQ
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
News Preview
Nurix presents new data from bexobrutideg Ph 1a/1b clinical trial in patients with r/r CLL and updates in patients with WM at #ASH25...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US9032141049
Cogent Biosciences, Inc.
COGT
LISTED
NASDAQ
Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting
News Preview
SUMMIT data for bezuclastinib in NonAdvSM selected for two oral presentations which will describe its best-in-class potential...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare management to present at upcoming investor conference
News Preview
GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conference.
Jefferies Global Healthcare Conference in London, England – Tuesday, November 18, 2025 at 9:30 am GMT/4:30 am ET/3:30 am CT
A webcast of this event can be accessed at the GE HealthCare website: https://in...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US92764N1028
Vir Biotechnology Inc
VIR
LISTED
NASDAQ
Vir Biotechnology Announces Completion of Enrollment in ECLIPSE 1 Phase 3 Trial for Chronic Hepatitis Delta
News Preview
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the completion of enrollment for ECLIPSE 1, a Phase 3 trial evaluating the safety and efficacy of the combination of tobevibart and elebsiran in patients with chronic hepatitis delta (CHD). ECLIPSE 1 is one of three trials in Vir Biotechnology’s ECLIPSE registrational program for CHD, and it is...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US90184D1000
Twist Bioscience Corp
TWST
LISTED
NASDAQ
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
News Preview
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that it has granted a total of 139,569 equity awards, consisting of 91,441 restricted stock units (“RSUs”) and up to 48,128 performance stock units (“PSUs”), to 41...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US2975841048
Estrella Immunopharma, Inc.
ESLA
LISTED
NASDAQ
Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluable Patients
News Preview
Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, today announced the successful completion of the second dose cohort in Phase I portion of its STARLIGHT-1 Phase I/II clinical trial...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk
News Preview
Pfizer Inc. today announced that it has filed a second lawsuit against Metsera, Inc., its controlling stockholders, and Novo Nordisk A/S in the United States District Court for the District of Delaware.
The lawsuit asserts that Novo Nordisk’s recent proposal to acquire Metsera constitutes an anticompetitive action by Novo Nordisk to protect its...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: CA71719L1067
Pharmala Biotech Holdings Inc.
MDMA
LISTED
CSE
PharmAla Files Final Base Shelf Prospectus and Signs Term Sheet with Radium Capital
News Preview
PharmAla files its final short form prospectus, and announces a signed term sheet with an R&D tax credit financing firm called Radium...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US31447E1055
Femasys Inc
FEMY
LISTED
NASDAQ
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million
News Preview
-- Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval -- -- $12 million senior secured convertible notes for total potential proceeds of $58 million, if all warrants are exercised for cash, reflecting strong investor confidence in Femasys’ wo...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: AU000000AVH4
Avita Medical Inc.
AVH
LISTED
ASX
Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment
News Preview
AVITA Medical data at SRBC 2025 confirms RECELL® as standard of care, improving healing, reducing hospital stays, and lowering treatment costs...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US0044685008
Achieve Life Sciences, Inc.
ACHV
LISTED
NASDAQ
Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation
News Preview
120-Day Safety Update Submitted to FDA ORCA-OL Long-Term Safety Trial Successfully ConcludedDSMC Completes Final Review of Cytisinicline, Finds No Drug Safety Concerns...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US46266A1097
IRadimed Corp
IRMD
LISTED
NASDAQ
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results
News Preview
Announces Regular Quarterly Cash Dividend of $0.17 Per Share and Raises Full-Year Guidance Announces Regular Quarterly Cash Dividend of $0.17 Per Share and Raises Full-Year Guidance...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: CH0499880968
ADC Therapeutics SA
ADCT
LISTED
NYSE
ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025
News Preview
LAUSANNE, Switzerland, Nov. 3, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it will host a conference call and live webcast on Monday, November 10, 2025, at 8:30 a.m. EST to report financia...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US1374041093
Candel Therapeutics, Inc.
CADL
LISTED
NASDAQ
Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London
News Preview
NEEDHAM, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that Paul Peter Tak, M.D., Ph.D., FMedSci, Candel’s President and Chief Executive...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US14888U1016
Catalyst Pharmaceuticals Inc
CPRX
LISTED
NASDAQ
Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference
News Preview
CORAL GABLES, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Rich Daly, Presiden...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US74168J1016
Prime Medicine Inc
PRME
LISTED
NASDAQ
Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer
News Preview
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer (CBO). Dr. Hawryluk will lead Prime’s corporate and...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the closing of its previously announced underwritten public offering of 21,131,250 common shares, without par value, which includes the exerci...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US92790C1045
Viridian Therapeutics Inc
VRDN
LISTED
NASDAQ
Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease
News Preview
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced the successful October submission of its BLA to the U.S. Food and Drug Administration (FDA) for veligrotug, the company’s investigational ther...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US48576U2050
Karyopharm Therapeutics Inc
KPTI
LISTED
NASDAQ
Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress
News Preview
– Top-Line Data from the Phase 3 SENTRY Trial in Myelofibrosis on Track for March 2026 –
– Total Revenue was $44.0 Million; U.S. XPOVIO® (selinexor) Net Product Revenue was $32.0 Million, an increase of 8.5% compared to Third Quarter of 2024 –...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter from SilverSummit Healthplan Offers Health Insurance in Nevada in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable plans from Ambetter from SilverSummit Healthplan statewide.
LAS VEGAS and RENO, Nev., Nov. 3, 2025 /PRNewswire/ -- Ambetter from SilverSummit Healthplan, a product offered by a Centene Cor...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter Health Offers Health Insurance in Florida in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable Ambetter Health plans in 63 counties.
FORT LAUDERDALE, Fla., Nov. 3, 2025 /PRNewswire/ -- Ambetter Health, a product offered by a Centene Corporation (NYSE: CNC) company, a leading healthcare enterprise t...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter Health Offers Health Insurance in Pennsylvania in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable plans from Ambetter Health in 39 counties.
HARRISBURG, Pa., Nov. 3, 2025 /PRNewswire/ -- Ambetter Health, a product offered by a Centene Corporation (NYSE: CNC) company, a leading healthcare enterprise t...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US63909J1088
Nautilus Biotechnology Inc
NAUT
LISTED
NASDAQ
Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
News Preview
• Buck Institute’s deployment of Nautilus’ instrument generates tau proteoform data, providing external validation of the company’s next-generation single-molecule proteomics platform • Joint research results show high reproducibility across sites and insight into novel tau biology, signaling a fundamental shift in how proteomics technology can adv...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: IL0011316309
Mediwound Ltd
MDWD
LISTED
NASDAQ
MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®
News Preview
MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US53635D2027
Liquidia Corp
LQDA
LISTED
NASDAQ
Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences
News Preview
MORRISVILLE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today that members of the company’s executive leadership team will be providing updates on the company's business during fireside chat...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: ES0167733015
Oryzon Genomics SA
ORY
LISTED
BME
ORYZON Announces First‑Patient‑In (FPI) in RESTORE Phase Ib Trial of Iadademstat in Sickle Cell Disease
News Preview
MADRID and CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical‑stage biopharmaceutical company and global leader in epigenetics, today announced that the first patient has been enrolled in RESTORE, its multi‑center, open‑label Phase Ib clinical trial of iadademstat in adults...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US8693671021
Sutro Biopharma Inc
STRO
LISTED
NASDAQ
Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference
News Preview
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced its participation at the 16th Annual World ADC Conference, taking place in San Diego, November 3-6, 2025....
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US1167941087
Bruker Corp
BRKR
LISTED
NASDAQ
Bruker Reports Third Quarter 2025 Financial Results
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and nine months ended September 30, 2025.
Frank H. Laukien, Bruker’s President and CEO, commented: “In the third quarter, we were encouraged by our mid-single digit percentage organic bookings growth year-over-year, with a Scientific Instruments segment book-to-bil...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US91307C1027
United Therapeutics Corp
UTHR
LISTED
NASDAQ
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
News Preview
United Therapeutics Corporation (Nasdaq: UTHR) today announced the first clinical xenotransplantation in its EXPAND study of the UKidney™ in patients with end-stage renal disease (ESRD). The successful transplant operation was performed at NYU Langone Health.
United Therapeutics’ UKidney is an investigational xenokidney from a pig with 10 gene e...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US74766Q1013
Quanterix Corp
QTRX
LISTED
NASDAQ
Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025
News Preview
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Monday, November 10, 2025, at 4:30 p.m. E.T., to discuss its third quarter 2025 financial results.
Quanterix will issue a press release regarding its third quarter 2025 fi...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals to Host Third Quarter Financial Results Conference Call and Webcast on November 11, 2025
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) will host a conference call and webcast on Tuesday, November 11, 2025, at 8:30 a.m. ET to review the Company’s third quarter financial results and provide an operational update.
The live audio webcast will be accessible on the Investors section of the Company’s website at www.ir.kalvista.com/event-ca...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US3773221029
Glaukos Corp
GKOS
LISTED
NYSE
Glaukos Announces Participation in Upcoming Investor Conferences
News Preview
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the following upcoming investor conferences:
UBS Global Healthcare Conference on Tuesda...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US7133171055
PepGen Inc
PEPG
LISTED
NASDAQ
PepGen to Participate in Upcoming Investor Conferences
News Preview
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that management will participate in the following upcoming investor conferences:
Guggenheim Securities 2nd An...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb Showcases New Long-Term and Real-World Data From Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2025
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data from its cardiovascular portfolio at the American Heart Association’s Scientific Sessions 2025, taking place November 7–10, 2025 in New Orleans, Louisiana. New analyses include results from a long-term extension study and real-world evidence that reinforce how Camzyos (mavac...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Robbins Geller Rudman & Dowd LLP Announces that Avantor, Inc. (AVTR) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
SAN DIEGO, Nov. 3, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that the Avantor class action lawsuit – captioned Building Trades Pension Fund of Western Pennsylvania v. Avantor, Inc., No. 25-cv-06187 (E.D. Pa.) – seeks to represent purchasers or acquirers of Avantor, Inc. (NYSE: AVTR) comm...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bacterial Panels on BD COR™ System
News Preview
FRANKLIN LAKES, N.J., Nov. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Conformité Européenne (CE) marking in the European Union for its Enteric Bacte...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.
News Preview
The Merck Foundation announced today the launch of the Collaborative for Equity in Cardiac Care, a $22 million, five-year initiative aimed at enhancing access to high-quality, person-centered health care for people living with heart conditions in the U.S. Eleven organizations are receiving grants to support the development and implementation of ev...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
News Preview
Enrollment completed ahead of schedule, underscoring strong interest from patient community in a potential new therapeutic option...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US10806X1028
BridgeBio Pharma, Inc.
BBIO
LISTED
NASDAQ
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
News Preview
PALO ALTO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that ten moderated digital posters will be shared at the American Heart Association (AHA) Scientific Sessions 2025, taking place in New Orle...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
News Preview
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – will present new data from its felzartamab clinical development programs at Kidney Week 2025, the American Society of Nephrology’s (ASN) annual meeting, taking place November 5-9 in Houston, Texas. Felzartamab, an investigational anti-CD38 monoclonal antibody, is cur...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US45779A8466
InspireMD, Inc.
NSPR
LISTED
NASDAQ
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer
News Preview
MIAMI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the appointment of Peter A. Soukas, M.D., as Chief Medical Officer to advance its mission to deliver best-in-class tools for carotid intervention....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US03770N1019
Apogee Therapeutics Inc
APGE
LISTED
NASDAQ
Apogee Therapeutics to Participate in Upcoming Conferences
News Preview
SAN FRANCISCO and BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate at the following investor conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US26818M1080
Dyne Therapeutics Inc
DYN
LISTED
NASDAQ
Dyne Therapeutics to Present at Upcoming Investor Conferences
News Preview
WALTHAM, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to present at the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US00887A2042
Rein Therapeutics Inc
ALRN
LISTED
NASDAQ
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
News Preview
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US3441741077
Foghorn Therapeutics Inc
FHTX
LISTED
NASDAQ
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
News Preview
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the Guggenheim Second Annual Healthcare Innovation Confere...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US45168D1046
IDEXX Laboratories, Inc.
IDXX
LISTED
NASDAQ
IDEXX Laboratories Announces Third Quarter Results
News Preview
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results.
Third Quarter Results
The Company reports revenues of $1,105 million for the third quarter of 2025, an increase of 13% as reported and 12% organic, driven by Companion Animal Group ("CAG") growth of 14% as reported and...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US8064071025
Henry Schein Inc
HSIC
LISTED
NASDAQ
Henry Schein One and AWS Collaborate to Transform Global Dentistry with Generative AI
News Preview
Henry Schein One, a leading global provider of dental technology, today announced a groundbreaking partnership with Amazon Web Services (AWS), the world’s most comprehensive and broadly adopted cloud platform. Together, the companies will integrate AWS’s generative AI (GenAI) technologies across the Henry Schein One platform — including Dentrix, D...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
